You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS and USAGE:
PATADAY™ Solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis. 

Dosing and Administration: The recommended dose is one drop in each affected eye once a day.

IMPORTANT SAFETY INFORMATION:
PATADAY™ (olopatadine hydrochloride ophthalmic solution) 0.2% should not be used to treat contact lens related irritation. The preservative in PATADAY™ solution, benzalkonium chloride, may be absorbed by soft contact lenses. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATADAY™ Solution before they insert their contact lenses.  Safety and effectiveness in pediatric patients below the age of 3 have not been established.

Contraindications: PATADAY™ Solution is contraindicated in patients with a hypersensitivity to any components of this product.

Adverse Events: The most common adverse reations to PATADAY™ Solution were cold syndrome and pharyngitis reported at an incidence of approximatedly 10%. Other adverse events included eye pain, blurred vision, sinusitis and headache occuring in 5% or less of the patients.

As with any eye drop, to prevent contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep bottle tightly closed when not in use. Patients should be advised not to wear a contact lens if their eye is red.

Click here for full prescribing information.